Cargando…
The impact of the COVID-19 pandemic on head and neck cancer patients
Autores principales: | Chen, Gaili, Wu, Qiuji, Jiang, Huangang, Zhong, Yahua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330546/ https://www.ncbi.nlm.nih.gov/pubmed/32660894 http://dx.doi.org/10.1016/j.oraloncology.2020.104881 |
Ejemplares similares
-
Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients
por: Chen, Gaili, et al.
Publicado: (2020) -
Impact of the COVID-19 pandemic in the head and neck cancer treatment in the Brazil
por: Martelli, Alison José, et al.
Publicado: (2021) -
Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
por: Wu, Qiuji, et al.
Publicado: (2020) -
Daily life of head and neck cancer patients during the COVID-19 pandemic
por: Babin, E., et al.
Publicado: (2022) -
Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
por: Wu, Qiuji, et al.
Publicado: (2021)